AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.

AURKA (aurora kinase A) has been confirmed as an oncogene in cancer development; however, its role and underlying mechanisms in the metastasis of hepatocellular carcinoma (HCC) remain unknown. In this study, We found that AURKA was up-regulated in HCC tissues and correlated with pathological stage and distant metastasis. Further found that AURKA was involved in the cancer metastases after radiation in HCC. While overexpression of AURKA induced epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) behaviors though PI3K/AKT pathway, silencing AURKA suppressed radiation-enhanced cell invasiveness of HCC. Taken together, our results suggested that AURKA contributed in metastasis of irradiated residul HCC though facilitating EMT and CSC properties, suggesting the potential clinical application of AURKA inhibitors in radiotherapy for patients with HCC.

[1]  Peter Gais,et al.  Aurora Kinase A Messenger RNA Overexpression Is Correlated with Tumor Progression and Shortened Survival in Head and Neck Squamous Cell Carcinoma , 2006, Clinical Cancer Research.

[2]  F. Fang,et al.  Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix. , 2008, International journal of radiation oncology, biology, physics.

[3]  I. Mackenzie,et al.  Cancer stem cells and EMT in carcinoma , 2012, Cancer and Metastasis Reviews.

[4]  Sheng-Yao Su,et al.  Over-expression of AURKA, SKA3 and DSN1 contributes to colorectal adenoma to carcinoma progression , 2016, Oncotarget.

[5]  David J. Hunter,et al.  Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States) , 2006, Cancer Causes & Control.

[6]  I. Mackenzie,et al.  Roles of hypoxia, stem cells and epithelial-mesenchymal transition in the spread and treatment resistance of head and neck cancer. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[7]  C. Perez,et al.  Prognostic significance of pelvic recurrence and distant metastasis in prostate carcinoma following definitive radiotherapy. , 1992, International journal of radiation oncology, biology, physics.

[8]  P. Opolon,et al.  Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion , 2005, Molecular Cancer Therapeutics.

[9]  Jinsong Zhang,et al.  AURKA is a predictor of chemotherapy response and prognosis for patients with advanced oral squamous cell carcinoma , 2015, Tumor Biology.

[10]  miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A. , 2016, Biochemical and biophysical research communications.

[11]  Xiaomin Su,et al.  Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. , 2011, International journal of radiation oncology, biology, physics.

[12]  P. Ramani,et al.  Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma , 2015, Histopathology.

[13]  H. Zhang,et al.  AURKA promotes cell migration and invasion of head and neck squamous cell carcinoma through regulation of the AURKA/Akt/FAK signaling pathway. , 2016, Oncology letters.

[14]  D. Fan,et al.  The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links. , 2015, Current pharmaceutical design.

[15]  K. Takeda,et al.  Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C. , 2005, World journal of gastroenterology.

[16]  Lei Han,et al.  AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer , 2016, Oncotarget.

[17]  Quan Zhou,et al.  Activation of the FAK/PI3K pathway is crucial for AURKA-induced epithelial-mesenchymal transition in laryngeal cancer. , 2016, Oncology reports.

[18]  G. Scagliotti,et al.  Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation , 2011, Journal of Translational Medicine.

[19]  Alison Jones,et al.  Educating undergraduate medical students about oncology: a literature review. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Jenny C. Chang,et al.  Epithelial-mesenchymal transition, cancer stem cells and treatment resistance , 2012, Breast Cancer Research.

[21]  Qing Luo,et al.  Liver cancer stem cell markers: Progression and therapeutic implications. , 2016, World journal of gastroenterology.

[22]  G. Schwartz,et al.  Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[24]  K. Hanazaki,et al.  Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma. , 2005, Hepato-gastroenterology.

[25]  Xin-hua Liang,et al.  Links between cancer stem cells and epithelial–mesenchymal transition , 2015, OncoTargets and therapy.

[26]  M. Nieto,et al.  Inflammation and EMT: an alliance towards organ fibrosis and cancer progression , 2009, EMBO molecular medicine.

[27]  J. Bruix,et al.  Hepatocellular carcinoma , 2012, The Lancet.

[28]  Kyung-Ja Cho,et al.  Epithelial-Mesenchymal Transition , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.